Clinical Trials Browser

Interventional × Carcinoma, Lobular × Crizotinib × Clear all

NCT03620643 2025-10-30

ROLo

Phase 2 Completed

33 enrolled 13 charts

BreastGastrointestinal

Stomach Neoplasms, Carcinoma, Lobular, Triple Negative Breast Neoplasms